Fate Therapeutics Inc (FATE): Total Assets
$318.94M
As of 2025-12-31
$260.10M
As of 2026-06-30
-23.3%
3-year compound annual growth
-12.5%
5-year compound annual growth
+16.7%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $318.94M | -27.6% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $440.69M | -12.9% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $506.22M | -28.3% | 2025-03-05, Balance as of period end |
| 2022-12-31 | $705.56M | -23.4% | 2024-02-26, Balance as of period end |
| 2021-12-31 | $921.46M | +48.0% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $622.46M | +105.9% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $302.27M | +41.9% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $213.03M | +102.3% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $105.29M | +10.8% | 2019-03-05, Balance as of period end |
| 2016-12-31 | $95.05M | +39.9% | 2018-03-05, Balance as of period end |
| 2015-12-31 | $67.96M | +32.8% | 2017-03-16, Balance as of period end |
| 2014-12-31 | $51.18M | -7.9% | 2016-03-03, Balance as of period end |
| 2013-12-31 | $55.58M | +401.8% | 2015-03-12, Balance as of period end |
| 2012-12-31 | $11.08M | n/a | 2014-03-17, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Fate Therapeutics Inc (FATE) | 2025-12-31 | $318.94M | -27.6% |
| DBV Technologies S.A. (DBVT) | 2025-12-31 | $233.72M | +256.0% |
| Zeo ScientifiX, Inc. (ZEOX) | 2025-10-31 | $1.53M | -7.1% |
| Curis Inc (CRIS) | 2025-12-31 | $19.97M | -51.6% |
| Prime Medicine, Inc. (PRME) | 2025-12-31 | $342.73M | +15.2% |
| Taysha Gene Therapies, Inc. (TSHA) | 2025-12-31 | $343.32M | +114.1% |
| Ocugen, Inc. (OCGN) | 2025-12-31 | $43.52M | -47.2% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $79.73M | +57.1% |
| TScan Therapeutics, Inc. (TCRX) | 2025-12-31 | $228.79M | -38.4% |
Compare FATE, DBVT, ZEOX, CRIS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗